A Pilot Study of Switching From One Pain Medication to Another (Opioid Rotation)
NCT00580294 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 12
Last updated 2016-02-03
Summary
The purpose of this study is to see if changing from one pain medication like morphine or oxycodone to another pain medication, oxymorphone (OPANA®), will be helpful to patients. This study will examine if the switching from one pain medication to another can be done over a 24 hour period. Oxymorphone, the drug being studied, is an FDA approved drug for treatment of severe pain.
Conditions
Interventions
- DRUG
-
Oxymorphone
IV PO
Sponsors & Collaborators
-
Endo Pharmaceuticals
collaborator INDUSTRY -
Icahn School of Medicine at Mount Sinai
lead OTHER
Principal Investigators
-
Marco Pappagallo, MD · Icahn School of Medcine at Mount Sinai
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2007-11-30
- Primary Completion
- 2008-08-31
- Completion
- 2008-08-31
Countries
- United States
Study Locations
More Related Trials
-
A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain
NCT01427283 ·Status: COMPLETED ·Phase: PHASE3
-
Effects of Ethanol on Oxycodone Pharmacokinetics in Healthy Volunteers
NCT02165930 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Safety of Fentanyl Buccal Tablets Compared With Oxycodone for the Management of Break Through Pain
NCT00463047 ·Status: COMPLETED ·Phase: PHASE3
-
Preference for Subutex® (Buprenorphine) Versus Suboxone® (Buprenorphine/Naloxone) in Opioid Dependent Patients on Subutex® (Study P05094)(COMPLETED)
NCT00684073 ·Status: COMPLETED ·Phase: PHASE4
-
Analgesic Response to Opioid Analgesics in Buprenorphine-Maintained Individuals
NCT02136784 ·Status: UNKNOWN ·Phase: NA
-
Depot Naltrexone Treatment of Opioid Dependent Parolees
NCT00756990 ·Status: COMPLETED ·Phase: NA
-
A Study to Evaluate Unintended Prolonged Opioid Use
NCT04024397 ·Status: COMPLETED
-
A Randomised, Double Blind, Placebo and Active Controlled, Double Dummy,Parallel Group Study to Determine the Safety and Efficacy of Oxycodone/Naloxone Prolonged Release Tablets in Subjects With Moderate to Severe, Chronic Nonmalignant Pain
NCT01971632 ·Status: COMPLETED ·Phase: PHASE3
-
Buprenorphine Treatment: A Safe Alternative for Opioid Dependent Pain Patients
NCT01841931 ·Status: TERMINATED ·Phase: PHASE4
-
Multi-System Analysis of Opioid Receptor Binding
NCT05528848 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Multi-Center, Open-Label, 24-Week Study of OX219 Safety and Efficacy for Maintenance Treatment of Opioid Dependence
NCT01903005 ·Status: COMPLETED ·Phase: PHASE4
-
Opioid Rotation From Morphine to Methadone in Treatment of Non-malignant Pain
NCT00356083 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Abuse Potential of Oxymorphone Compared to Other Mu Opioid Agonists.
NCT03389750 ·Status: COMPLETED ·Phase: PHASE2
-
Dual-Orexin Antagonism As a Mechanism for Improving Sleep and Drug Abstinence in Opioid Use Disorder
NCT04262193 ·Status: TERMINATED ·Phase: PHASE2
-
OXN PR vs Placebo in Opioid-naive Subjects Suffering From Severe Pain Due to Bladder Pain Syndrome (BPS)
NCT01197261 ·Status: COMPLETED ·Phase: PHASE2
-
The Safety and Efficacy of the Buprenorphine Transdermal System (BTDS) in Subjects With Chronic Back Pain.
NCT00315445 ·Status: COMPLETED ·Phase: PHASE3
-
The Safety and Efficacy of the Buprenorphine Transdermal Delivery System in Subjects With Chronic Low Back Pain.
NCT00315874 ·Status: COMPLETED ·Phase: PHASE3
-
Blockade Efficacy of Buprenorphine/Naloxone For Opioid Dependence
NCT00134888 ·Status: COMPLETED ·Phase: NA
-
The Safety and Efficacy of Epidural Oxycodone
NCT02573909 ·Status: UNKNOWN ·Phase: PHASE4
-
Nasal Human Abuse Potential of PTI-821
NCT03475862 ·Status: COMPLETED ·Phase: PHASE1
-
The Potential of Oxytocin to Reduce Opioid Abuse Liability and Pain Among Older Adults
NCT05761860 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
The Effects of Opioid Taper on Opioid-Induced Hyperalgesia
NCT03063905 ·Status: TERMINATED
-
Buprenorphine Transdermal System (BTDS) in Subjects With Moderate to Severe Chronic Low Back Pain
NCT00490919 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Assess Efficacy and Safety of BNX Sublingual Tablets for the Induction of Treatment of Opioid Dependence
NCT01848054 ·Status: COMPLETED ·Phase: PHASE3
-
Rapid Opiate Detoxification and Naltrexone Induction Using Buprenorphine - 2
NCT00000299 ·Status: COMPLETED ·Phase: PHASE2